Education
About Us
Working with TipRanks
Follow Us
Chemed (CHE)
:CHE
CHE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$512.12 - $623.61
Previous CloseN/A
Volume12.19K
Average Volume (3M)132.11K
Market Cap
$8.51B
Enterprise Value$8.31B
Total Cash (Recent Filing)$173.88M
Total Debt (Recent Filing)$145.06M
Price to Earnings (P/E)28.3
Beta0.19
Next Earnings
Jul 23, 2025EPS Estimate
6.04Next Dividend Ex-Date
May 29, 2025Dividend Yield0.33%
Share Statistics
EPS (TTM)5.63
Shares Outstanding14,629,484
10 Day Avg. Volume120,600
30 Day Avg. Volume132,108
Financial Highlights & Ratios
PEG Ratio8.91
Price to Book (P/B)7.06
Price to Sales (P/S)0.00
P/FCF Ratio26.48
Enterprise Value/Market Cap0.98
Enterprise Value/Revenue0.86
Enterprise Value/Gross Profit9.96
Enterprise Value/Ebitda4.69
Forecast
1Y Price Target
$677.33Price Target Upside20.64% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Chemed News
PremiumCompany Announcements
Chemed Holds Annual Stockholders Meeting on Key Decisions
PremiumCompany Announcements
Chemed’s Earnings Call: Mixed Sentiment with Growth and Challenges
PremiumCompany Announcements
Chemed Corporation Reports Strong Q1 2025 Results
Bulls Say, Bears Say
Bulls Say
Market DemandGoogle searches for 'plumbing' in Q1 2025 jumped 16% quarter-over-quarter, indicating strong demand for Roto-Rooter services.
Pricing PowerRoto has the ability to push higher prices to consumers while most of its services are need-based, providing a potential advantage.
Revenue GrowthRoto revenues came in much better and grew year over year, which is a welcome sign given the declines last year.
Bears Say
Regulatory ChallengesGiven the increase in the Medicare cap is below the overall Medicare rate increase for Vitas, Vitas would be over the cap in some of its markets.
Revenue DeclineVitas Q4 revenues were 3% below estimate and 1% below consensus due to worse margins from hurricanes and lower acuity headwind.
Options Prices
Currently, No data available
---
Ownership Overview
1.31% Insiders
28.94% Mutual Funds
27.29% Other Institutional Investors
16.40% Public Companies and Individual Investors
CHE FAQ
What was Chemed’s price range in the past 12 months?
Chemed lowest stock price was $512.12 and its highest was $623.61 in the past 12 months.
What is Chemed’s market cap?
Chemed’s market cap is $8.51B.
When is Chemed’s upcoming earnings report date?
Chemed’s upcoming earnings report date is Jul 23, 2025 which is in 61 days.
How were Chemed’s earnings last quarter?
Chemed released its earnings results on Apr 23, 2025. The company reported $5.63 earnings per share for the quarter, beating the consensus estimate of $5.547 by $0.083.
Is Chemed overvalued?
According to Wall Street analysts Chemed’s price is currently Undervalued.
Does Chemed pay dividends?
Chemed pays a Quarterly dividend of $1.9 which represents an annual dividend yield of 0.33%. See more information on Chemed dividends here
What is Chemed’s EPS estimate?
Chemed’s EPS estimate is 6.04.
How many shares outstanding does Chemed have?
Chemed has 14,629,484 shares outstanding.
What happened to Chemed’s price movement after its last earnings report?
Chemed reported an EPS of $5.63 in its last earnings report, beating expectations of $5.547. Following the earnings report the stock price went down -6.607%.
Which hedge fund is a major shareholder of Chemed?
Currently, no hedge funds are holding shares in CHE
Chemed Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$677.33 (20.64% Upside)
$677.33 (20.64% Upside)
Blogger Sentiment
Bullish
CHE Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 79.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $5.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 9.6%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
0.93%
12-Months-Change
Fundamentals
Return on Equity
26.11%
Trailing 12-Months
Asset Growth
-0.06%
Trailing 12-Months
Company Description
Chemed
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in two segments, VITAS and Roto-Rooter. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
CHE Company Deck
CHE Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with strong growth in VITAS admissions and revenue, supported by strategic acquisitions such as Covington Health. However, Roto Rooter faced challenges with declining EBITDA and contractor revenue, alongside the need to carefully manage Medicare cap constraints. While there are positive growth indicators, particularly for VITAS, Roto Rooter's performance and cap management issues present notable hurdles.Read More>CHE Stock 12 Month Forecast
Average Price Target
$677.33
▲( 20.64% Upside)